On February 24th, the Academic Symposium - 2023 (9th) Probiotics International Summit Forum was officially held, which was jointly organized by Guang Dong Institute of Food Science and Technology and Information Times, and co-organized by H&H Group.

The conference brought together authoritative experts, researchers, universities, institutes and high-quality enterprises in the probiotic industry, focusing on the development and future trends of probiotics, and discussing in-depth the cutting-edge advances in the field of probiotics and the results of scientific research, and the innovative transformation of the industry, which opened a summit of academic exchanges under the theme of ""Bacteria" Equalize Health, "Benefit" and Immunity".

Focusing on probiotics, intestinal flora and immunity, this year's Summit Forum invited a number of renowned scholars, medical experts and enterprise representatives in the industry, aiming to build a professional and systematic academic exchange platform for probiotics, and to provide a comprehensive communication channel for the popularization and promotion of probiotics and prebiotics.

The forum was opened under the speeches of Li Biansheng, chairman of Guang Dong Institute of Food Science and Technology, Lun Shaobin, deputy editor-in-chief of Information Times, and Yu Yongjian, general manager of Information Times All-Media Operation Center, etc. The authoritative experts and scholars discussed the latest researches in the fields of "human microecology group", "probiotics for infants and young children", etc. The authoritative experts and scholars focused on the latest research hotspots in the fields of "human microecology group" and "infant intestinal probiotics", and actively shared their professional views on the healthy development of probiotic industry, academia, research and utilization.

Li Biansheng, Chairman of Guangdong Food Society

Among them, Prof. Lijun You, Professor of the School of Food Science and Engineering of South China University of Technology and Deputy Secretary General of the International Association for Food Nutrition and Safety, shared a research report on "Research on the Efficacy of Seaweed Polysaccharides in Regulating Lipid Metabolism". Prof. You Lijun said, "Seaweed polysaccharides have the effect of regulating lipid metabolism, in addition, seaweed polysaccharides are able to maintain the body's intestinal flora homeostasis and regulate the immune response. Research on seaweed polysaccharides is expected to become one of the hotspots in the field of life sciences in the future."

Dr. Xie Xinqiang, Chief Scientist of the National Key R&D Program (Synthetic Biology) and Project Leader of the Guangdong Key Area R&D Program, gave a presentation titled "Progress in the Research and Application of Probiotics that can be Used in Infants and Young Children". Dr. Xie shared, "Research shows that the human microbiome is closely related to human health. Proper supplementation of probiotics can enhance resistance and help regulate the balance of intestinal flora."

Subsequently, Deng Yuhong, Chief Physician of Neurology and Deputy Director of Clinical Nutrition Department of the Second Affiliated Hospital of Guangzhou Medical University, gave a keynote report on the topic of "Nutritional-Gut Microecology Technology: Advancement of Medicine". The report illustrated that the development of intestinal microecology technology can promote the innovation of basic and applied science.

As a global leading brand of probiotic nutrition for infants and children, Biostime has always been committed to the research of infant and young children's intestinal health. In this meeting, Hu Ruibiao, R&D Director of BNC, H&H Group China, made a special report on "Progress of Research and Application of Probiotics for Infants and Young Children", which systematically introduced the clinical research results of probiotics for infants and young children, which is widely concerned in the industry.

The report pointed out that the intestinal flora of infants and young children is easily affected by various factors such as the mode of delivery, gestational age, feeding style, the use of antibiotics, etc. Appropriate supplementation of validated probiotics can help infants and young children to recover and maintain the intestinal flora and thus improve their health. For more than a decade, more than 26 clinical trials have been conducted in 5 countries (China, France, Spain, Serbia, Italy) for the probiotic strains of Biostime, with validated clinical functions including immune health, intestinal health, thrush, and more. Hu Ruibiao mentioned that Hershey's has always been committed to the maternal and child health industry, and will continue to conduct in-depth research on probiotics with the concept of making people healthier and happier in the future.

Hu Ruibiao, BNC R&D Director, H&H Group China

The Microecology Research Center of the Biostime Institute of Nutrition and Care (BINC) established by Biostime has already laid a solid foundation in the fields of microecology, probiotics and prebiotics. Up to now, Biostime has brought consumers a wide range of probiotic-containing products such as Biostime Children's Probiotic, Biostime Children's Probiotic Complex Platinum, Biostime Probiotic Drops, Biostime Lactoferrin + Probiotic Milk Powder, and Biostime Children's Probiotic + Lutein Esters Pressure Tablet Candy.

In February this year, the first probiotic and maternal and child health engineering technology research center of He Sheng Yuan was also recognized at the provincial level and was selected to be on the list of Guangdong engineering technology research centers in 2022, which is an authoritative recognition of the comprehensive strength of He Sheng Yuan's scientific research. Through the transformation of innovative achievements, He Sheng Yuan has increased the power of probiotic research to further meet the escalating consumer demand for probiotic products in terms of efficacy and usage scenarios.

In addition, the topic of "Probiotics and Infant Intestinal Health" has attracted a lot of attention from experts and scholars at the conference during the roundtable salon session. It has become a consensus that only when enterprises and the industry join hands can we promote the good development of the probiotic industry, and the dialog has brought professional and comprehensive thinking for the industry's high-quality and sustainable development.

Probiotics are the highlight of the new industry and consumption in the 21st century. As the scientific community continues to dig deeper into the richer potential of probiotics, they are gradually being explored and applied to a variety of niche areas. Along with the continuous upgrading of consumer demand, probiotic research and industrial development also ushered in a period of rapid development opportunities. How to cope with the new opportunities brought by new technologies, new demands and new business forms in the industry has become the strategic thinking and industry planning of China's probiotic industry.

Nowadays, H&H Group actively participates in the seminar, joins hands with many research institutes, famous dairy products, experts and scholars in the field of probiotics, continues to deepen its own technological advantages, and relies on the scientific research platforms such as BINC to increase the research and development of new probiotic products and technologies, which will bring a positive significance to further promote the future development of the probiotic industry.

Adhering to the PPAE business model of Premium, Proven, Aspirational and Engaging, it is foreseeable that the potential of the probiotic market for infants and young children will explode, and Jianhe Group's focus on transmitting the scientific knowledge of probiotics in a more scientific way will further implement the "Healthy China 2030 Initiative", and contribute scientific research to the iterative upgrading of the industry.